Manuela LECUYER

Nicolas Ploquin succeeds Markus Boehringer as CEO of Acteon Group   Nicolas's mission will be to continue Acteon's successful development over the past years to foster its position as one of the leading dental companies in its key market segments (prophylaxis, imaging, consumables). He will continue to execute the commercial acceleration and operational improvement pathway for the group.   He will continue focusing on Acteon's recognized excellence in R&D, which has just launched “OPUS”, a combined Ultrasonics & Air Polisher, X-MIND OPTIMA 3D, a new CBCT boosted by AI, and C20, an ultra-ergonomic HD intra-oral camera. All three products perfectly designed to improve diagnostic and patient care in the dental office.   Markus Boehringer will stay with Acteon Group as Vice-Chairman of the Supervisory Board. He will continue to provide his strategic expertise and support, particularly in guiding the further development of Acteon’s anesthetics business, as well as in driving R&D and product innovation.   Nicolas Ploquin, CEO of Acteon: "I am very happy to be joining Acteon and to take on the responsibility of growing such an iconic company in the dental sector, recognized for the quality of its products and its capacity for innovation. I look forward to accelerating the launch of new solutions supporting dental practitioners in delivering better patient care and advancing oral health for tens of millions of people worldwide. I’m also thrilled to have Markus on board and to capitalize on his extensive experience".   Markus Boehringer, Vice-Charmain of Acteon Supervisory Board: “After leading the launch of several outstanding products and the successful joint acquisition of Inibsa, I am delighted to hand over the leadership of Acteon to Nicolas as my successor as CEO. I now look forward to being the Vice-Chairman of the Group, where my focus will be on supporting the company's further growth and development and serving as a strategic resource for Nicolas and his team. DENTRESSANGLE

588

115 commentaires

📢 MedTech Europe unveils Facts & Figures 2025, a snapshot of innovation and impact in Europe   Europe’s medical technology sector 🔬 continues to grow as a powerhouse of innovation and economic strength, according to Facts & Figures 2025, published today by MedTech Europe.   The report reveals a sector that is both highly innovative and deeply rooted in Europe’s economy and health systems: ✅  930,000+ people employed: more than the population of Amsterdam, with each role generating €183,000 in value. ✅  Europe is home to 38,000+ companies, 90% of them SMEs, many with fewer than 50 employees, yet driving innovation across borders. ✅  15,700+ patents filed in 2024, equal to one every 30 minutes, confirming medtech’s place among the leading fields at the European Patent Office. MedTech Europe’s Facts & Figures 2025 is the most comprehensive resource on Europe’s medical technology sector. Designed as a practical tool, the report draws on trusted sources, including Eurostat, the European Patent Office, and market analyses, to provide an authoritative overview for policymakers, healthcare professionals, and industry stakeholders.   The Facts & Figures 2025 is available here➡️https://bit.ly/3VrLpPV

199

7 commentaires

💡 Quick Minds Episode 9 with PD Dr. Dr. med. Florian Früh,   New plates, new perspectives - here’s what's actually changing. In this fast-paced, 90-second interview, Dr. Florian Früh - the very first surgeon worldwide to use the Y-plate for a complex finger fracture - opens up about his hands-on experience, the benefits he’s seen with the new Medartis hand plate system, and his personal vision for the future of hand surgery.   Get inspired by Dr. Früh’s insights and discover what’s driving the next generation of fracture fixation. Tune in now!   #QuickMinds #HandTrauma #FractureFixation #ImplantInnovation 

94

1 commentaire

“You can’t outrun your genes – but maybe you can modify the journey a bit.” That’s the opinion of board-certified plastic surgeon and Galderma Aesthetic Injector Network (GAIN) faculty member Dr. Andreas Nikolis. With this mindset, he has not only helped shape the future of aesthetics, but also how to teach, plan and deliver patient outcomes around the world. In this episode of Beauty x Medicine, Dr. Nikolis joins our CEO, Flemming Ornskov, MD, MPH, to reflect on 10 years of GAIN and the changing field of aesthetic medicine. From treating the lower part of the face to the aesthetic impact of medication-driven weight loss, Dr. Nikolis provides insight into how the latest approaches and tools are helping support a new generation of patients. GAIN is at the forefront of innovation in this space, and as one of the network’s longest-standing members, Dr. Nikolis has been instrumental in shaping what is possible today. In the lead-up to the next GAIN event this month in Athens, Greece, find out more insights from one of dermatology’s leading voices. #AdvancingDermatology #BeautyXMedicine #GAIN

177